Anonymous
Guest
Anonymous
Guest
Is there a link? http://clinicaltrials.gov/ct2/show/NCT00463580#miller infliximab depression Clearly, we are far beyond the simplistic monamine hypothesis now. Thoughts?
That much! Do you think Lilly could come up with a better anti-inflammatory?
Just askin'
Infliximab can cost $19,000 to $22,000 a year per patient wholesale, according to Centocor. Insurance will never pay for that for treating depression. Wasted trial. Cymbalta clearly better.
depression is more than seratonin and norepinephrine. High levels of norepinephrine lead to anxiety so giving a patient crap like cymbalta can make them worse....and long term use causes neurotransmitter depletion.Then patients are back to depression again, with depleted Nt's. Know what you're selling dumb dumb.